Indeed, In1-ghrelin peptides and native-ghrelin treatment evoked a signaling response in terms of changes in the [Ca2+]i, a key second messenger that has been previously linked to ghrelin-system signaling [22, 34] and is functionally associated to PCa-pathophysiology. The gene discussed is GHRL; the disease is posterior cortical atrophy.